Latest News
These are CLL Ireland’s latest news posts from Facebook – but make sure to visit our CLL Ireland Facebook page for older posts.
Just 289 doses of Covid treatment tablet Paxlovid administered so far in Ireland
www.irishexaminer.com
Paxlovid can be taken within five days of a Covid-19 infection to stop the illness from progressing. Trials found it cut hospitalisations and deaths by 88%. Currently 18 representatives from the clinical community and medical societies, amongst others @EHA_Hematology @Ericllorg @iwCLL and @BritSocHaem, have endorsed the #ICBCC mission. You can find all endorsers listed in this joint statement: www.icbcc.info/patient-impact-statement #considerthecompromised ![]()
![]()
Association Capucine Cent Pour Sang La Vie Fédération Leucémie Espoir Laurette Fugain José Carreras Leukämie-Stiftung DKMS Deutschland
Important high risk patients have a plan in place to access #Paxlovid if they contract Covid.![]()
Seek advice from your gp or consultant about eligibility and how to access,so you can form that plan.![]()
#Paxlovid works better in the first five days so act fast.![]()
#ForUsAll ![]()
t.co/sHnvH5UFxB
The International COVID-19 Blood Cancer Coalition #ICBCC is calling upon stakeholders in health policy and health care to enable access for #immunocompromised blood cancer patients to life-saving therapies before, during and after infection, and advocates for fundamental changes to accommodate the specific needs of these patients in general and for the time of the COVID-19 pandemic. #considerthecompromised ![]()
![]()
Cancer Support Community Lymphoma Research Foundation Patient Power Asociación Linfomas Argentina Celebrando la Vida ABRALE - Associação Brasileira de Linfoma e Leucemia
The International COVID-19 Blood Cancer Coalition #ICBCC is calling upon stakeholders in health policy and health care to enable access for #immunocompromised blood cancer patients to life-saving therapies before, during and after infection, and advocates for fundamental changes to accommodate the specific needs of these patients in general and for the time of the COVID-19 pandemic. #considerthecompromised ![]()
![]()
Cancer Support Community Lymphoma Research Foundation Patient Power Asociación Linfomas Argentina Celebrando la Vida ABRALE - Associação Brasileira de Linfoma e Leucemia
While vaccines are an effective defense against severe COVID-19 for most people, about 25 % of #immunocompromised blood cancer patients can't produce COVID-19 antibodies after vaccination. Those patients carry a high risk of infection and severe disease course. #ICBCC #considerthecompromised ![]()
![]()
The Leukemia & Lymphoma Society of Canada - Prairies/Territories Region Agalemo - Leucemia Costa Rica - LMC Lymphoma Coalition HealthUnlocked LYMFOM HELP Suomen Syöpäpotilaat ry
#ICBCC calls on all scientists researching blood cancers to influence decision makers and promote specific research on COVID-19 and #immunocompromised blood cancer patients, as well as existing and future antiviral and monoclonal antibody treatments. #considerthecompromised ![]()
![]()
Blood Cancer Society Nepal 한국혈액암협회 Lymphoma Canada CLL Society Inc. The Leukemia & Lymphoma Society Asociación Leucemia Mieloide Argentina
More than 1 in 4 immunocompromised blood cancer patients do not produce COVID-19 antibodies after vaccination and carry a high risk of infection, severe disease course and death. Therefore, #ICBCC calls for a change in health policy in terms of early access to life-saving therapies before, during and after Infection to protect the most vulnerable! #considerthecompromised ![]()
![]()
Leukämie-Online Deutsche Leukämie- & Lymphom-Hilfe e.V. CLL Ireland AIL Associazione Italiana contro le Leucemie-linfomi e mieloma ONLUS ХЕМА - HEMA Hematon
Uncovering the Value of Real-World Data for Blood Cancer
Published News